Denise Drace-Brownell, J.D., M.PH. is a Senior Managing Director at Epsilon Securities LLC in New York City, affiliated with the Psilos Group, a successful private equity firm.She is a member of the Board of Directors of ZS Genetics, Inc. With extensive strategic advisory, M&A, licensing, intellectual property, marketing and transactions experience, she has a track record in solving complex business challenges.She has accomplished profitable growth initiatives, turnarounds, and premium sales of companies. She has held CEO, VP Corporate Development and General Counsel positions for a number of technology organizations, including life sciences and engineering corporations.Earlier she was Practice President of the medical branding unit of McCann Worldgroup, and a corporate attorney in Akzo Nobel’s US M&A unit. Her clients have included Fortune 500s, mid-size, and development stage companies, including J&J, Myriad Genetics and Chevron. Ms. Drace-Brownell holds a B.S. from the University of Illinois; a Masters in Public Health (Toxicology) from Columbia University; and a J.D. from Rutgers University/University of Pennsylvania. She has served as counsel to governors and state governments on energy and waste management matters, and has long been involved with climate change research initiatives at Columbia University.